BackgroundCheck.run
Search For

Shaila Rahman, 44409 Walden St, Cambridge, MA 02138

Shaila Rahman Phones & Addresses

409 Walden St, Cambridge, MA 02138   

Brookline, MA   

Houston, TX   

Roxbury Crossing, MA   

Rockville, MD   

Missouri City, TX   

13 Ellery St APT 3, Cambridge, MA 02138   

Get Report
Control this profile

Mentions for Shaila Rahman

Shaila Rahman resumes & CV records

Resumes

Shaila Rahman Photo 22

Shaila Rahman

Location:
1 Memorial Dr, Cambridge, MA 02142
Industry:
Biotechnology
Work:
Flagship Ventures - Cambridge, MA since Oct 2012
Associate Flagship Ventures - Cambridge, MA Jun 2012 - Aug 2012
VentureLabs Entrepreneurial Fellow Harvard Biotechnology Club Jan 2008 - May 2012
Chair Harvard Medical School Aug 2006 - May 2012
Doctoral Candidate Dana Farber Cancer Institute Jul 2004 - Jun 2006
Research Assistant National Cancer Institute Jul 2003 - Dec 2003
Research Assistant
Education:
Harvard University/Harvard Medical School 2006 - 2012
PhD, Virology Colgate University 2000 - 2004
BA, Molecular Biology
Skills:
Microbiome, Early Stage Startups, Gene Expression, Proteomics, Viral Host Interactions, Genomics, Biotechnology, Immunology, Virology, Epigenetics, Life Sciences, Molecular Biology, Gene Expression Regulation, Entrepreneurship, Microbiology, Fluorescence Microscopy, Structural Biology, Protein Chemistry, Cancer Biology
Shaila Rahman Photo 23

Shaila Rahman

Shaila Rahman Photo 24

Shaila Rahman

Shaila Rahman Photo 25

Shaila Rahman

Publications & IP owners

Us Patents

Nutritive Polypeptides And Formulations Thereof, And Methods Of Production And Use Thereof

US Patent:
2020030, Oct 1, 2020
Filed:
Mar 16, 2020
Appl. No.:
16/819817
Inventors:
- Cambridge MA, US
Brett Boghigian - Boston MA, US
Caitlyn Harvey - Wilmington MA, US
David Berry - Brookline MA, US
David Young - Portsmouth NH, US
Geoffrey Von Maltzahn - Boston MA, US
John Kramarczyk - Somerville MA, US
Jameson Rogers - Cambridge MA, US
Kathryn Heard - Watertown MA, US
Michael Doherty - Somerville MA, US
Nathaniel Silver - Cambridge MA, US
Phillip Samayoa - Cambridge MA, US
Subhayu Basu - Chestnut Hill MA, US
Shaila Rahman - Cambridge MA, US
Vimal Vaidya - Watertown MA, US
International Classification:
A61K 38/17
G16B 20/00
A61K 38/00
A23L 33/00
A23L 33/17
A23L 33/18
A23L 33/175
A61K 38/38
A61K 9/00
A61K 9/14
A61K 9/20
A61K 9/28
G01N 33/68
A23L 2/66
A61K 38/16
A61K 45/06
A23L 33/195
A61K 38/10
A61K 38/45
Abstract:
Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.

Nutritive Polypeptides And Formulations Thereof, And Methods Of Production And Use Thereof

US Patent:
2020018, Jun 18, 2020
Filed:
Sep 27, 2019
Appl. No.:
16/585357
Inventors:
- Cambridge MA, US
Brett Boghigian - Boston MA, US
Caitlyn Harvey - Wilmington MA, US
David Berry - Brookline MA, US
David Young - Portsmouth NH, US
Geoffrey Von Maltzahn - Boston MA, US
John Kramarczyk - Somerville MA, US
Jameson Rogers - Cambridge MA, US
Kathryn Heard - Watertown MA, US
Michael Doherty - Somerville MA, US
Nathaniel Silver - Cambridge MA, US
Phillip Samayoa - Cambridge MA, US
Subhayu Basu - Chestnut Hill MA, US
Shaila Rahman - Cambridge MA, US
Vimal Vaidya - Watertown MA, US
International Classification:
A61K 38/17
G16B 20/00
A61K 38/00
A23L 33/00
A23L 33/17
A23L 33/18
A23L 33/175
A61K 38/38
A61K 9/00
A61K 9/14
A61K 9/20
A61K 9/28
G01N 33/68
A23L 2/66
A61K 38/16
A61K 45/06
A23L 33/195
A61K 38/10
A61K 38/45
Abstract:
Nutritive polypeptides are provided herein. Also provided are various other embodiments including nucleic acids encoding the polypeptides, recombinant microorganisms that make the polypeptides, vectors for expressing the polypeptides, methods of making the polypeptides using recombinant microorganisms, compositions and formulations that comprise the polypeptides, and methods of using the polypeptides, compositions and formulations.

Probiotic Compositions Containing Clostridiales For Inhibiting Inflammation

US Patent:
2020006, Feb 27, 2020
Filed:
Aug 23, 2019
Appl. No.:
16/549950
Inventors:
- Cambridge MA, US
Johanne Kaplan - Sherborn MA, US
Shaila Rahman - Cambridge MA, US
International Classification:
A61K 35/74
A61K 31/7016
A61K 9/19
A61K 35/747
A61K 35/745
A61K 35/742
A61K 9/00
A61K 35/39
A61K 38/46
A61K 31/715
A61K 35/744
A61K 31/7004
A61K 35/741
Abstract:
Pharmaceutical compositions containing microbial entities are described herein. The pharmaceutical compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the pharmaceutical compositions to treat or prevent disorders of the local or systemic microbiome in a subject are also provided.

Probiotic Compositions Containing Clostridiales For Inhibiting Inflammation

US Patent:
2019033, Nov 7, 2019
Filed:
Dec 13, 2018
Appl. No.:
16/219125
Inventors:
- Cambridge MA, US
Johanne Kaplan - Sherborn MA, US
Shaila Rahman - Cambridge MA, US
International Classification:
A61K 35/74
A61K 35/741
A61K 35/742
A61K 31/7004
A61K 31/715
A61K 35/744
A61K 9/00
A61K 9/19
A61K 35/747
A61K 35/745
A61K 35/39
A61K 38/46
A61K 31/7016
Abstract:
Pharmaceutical compositions containing microbial entities are described herein. The pharmaceutical compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the pharmaceutical compositions to treat or prevent disorders of the local or systemic microbiome in a subject are also provided.

Probiotic And Prebiotic Compositions, And Methods Of Use Thereof For Treatment And Prevention Of Graft Verses Host Disease

US Patent:
2018016, Jun 21, 2018
Filed:
Jul 31, 2017
Appl. No.:
15/664310
Inventors:
- Cambridge MA, US
Noubar B. Afeyan - Lexington MA, US
Johanne Kaplan - Sherborn MA, US
Neal Gordon - Brookline MA, US
Shaila Rahman - Cambridge MA, US
International Classification:
A61K 35/74
A61K 35/741
A61K 38/46
A61K 35/747
A61K 35/745
A61K 35/744
A61K 35/742
A61K 9/00
A61K 35/39
A61K 31/715
A61K 31/7016
A61K 31/7004
A61K 9/19
A61K 35/00
Abstract:
Probiotic compositions containing non-pathogenic microbial entities, e.g., bacterial or fungal entities, are described herein. The probiotic compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the probiotic compositions to treat or prevent transplant disorders, e.g., graft-versus-host disease (GVHD), in a subject are also provided.

Probiotic And Prebiotic Compositions, And Methods Of Use Thereof For Treatment And Prevention Of Graft Versus Host Disease

US Patent:
2018007, Mar 15, 2018
Filed:
Apr 24, 2017
Appl. No.:
15/495522
Inventors:
- Cambridge MA, US
Noubar B. Afeyan - Lexington MA, US
Johanne Kaplan - Sherborn MA, US
Neal Gordon - Brookline MA, US
Shaila Rahman - Cambridge MA, US
International Classification:
A61K 35/74
A61K 38/46
A61K 9/00
A61K 35/39
A61K 31/715
A61K 31/7016
A61K 31/7004
A61K 9/19
A61K 35/00
Abstract:
Probiotic compositions containing non-pathogenic microbial entities, e.g., bacterial or fungal entities, are described herein. The probiotic compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the probiotic compositions to treat or prevent transplant disorders, e.g., graft-versus-host disease (GVHD), in a subject are also provided.

Probiotic Compositions Containing Clostridiales For Inhibiting Inflammation

US Patent:
2018001, Jan 18, 2018
Filed:
Feb 21, 2017
Appl. No.:
15/438271
Inventors:
- Cambridge MA, US
Johanne Kaplan - Sherborn MA, US
Shaila Rahman - Cambridge MA, US
International Classification:
A61K 35/74
A61K 9/00
A61K 35/39
A61K 31/7016
A61K 31/7004
A61K 9/19
A61K 38/46
A61K 31/715
A61K 35/00
Abstract:
Pharmaceutical compositions containing microbial entities are described herein. The pharmaceutical compositions may optionally contain or be used in conjunction with one or more prebiotics. Uses of the pharmaceutical compositions to treat or prevent disorders of the local or systemic microbiome in a subject are also provided.

Nsd3 Inhibitors For Treatment Of Cancers

US Patent:
2017000, Jan 12, 2017
Filed:
Jan 23, 2015
Appl. No.:
15/114020
Inventors:
- Boston MA, US
- Cambridge MA, US
Erica Marlene WALSH MICHEL - Somerville MA, US
Shaila RAHMAN - Cambridge MA, US
Simone KUHNLE - Cambridge MA, US
Assignee:
THE BRIGHAM AND WOMEN'S HOSPITAL, INC. - Boston MA
PRESIDENT AND FELLOWS OF HARVARD COLLEGE - Cambridge MA
International Classification:
A61K 31/47
G01N 33/574
C12Q 1/68
A61K 31/5517
A61K 31/4745
Abstract:
The present invention relates to the use of NSD3i inhibitors for the treatment of cancer. In particular, the present invention relates to methods, kits and compositions comprising NSD3 inhibitors to treat cancers dependent on NSD3, in particular subjects with NUT midline carcinoma (NMC) and subjects with NSD3/NUT or BRD4/NUT or BRD3/NUT fusion genes, as well as subjects with BRD4-dependent (but NUT-independent cancers). The present invention also relates to methods, kits and compositions comprising BET inhibitors for the treatment of subjects with NSD3/NUT fusion genes. Other aspects of the invention relate to assays and methods to identify an inhibitor of NSD3 which disrupts or decreases the interaction of the NSD3 protein with the ET do main of BRD4.

Possible Relatives

Daisy R Rahman  Dalia Rahman  Daoud D Rahman  Derrick Rahman  Dilshad Rahman  Ebadur Rahman  Ehsan U Rahman  Shaila Johnson  Shaila R Pimentel  Shaila Patel 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.